SARS-CoV Recombinant S Protein Vaccine

recombinant SARS-CoV spike (S) protein vaccine · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SARS-CoV Recombinant S Protein Vaccine, covering 2013-02-15 to 2013-02-15. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Dose Escalation SARS-CoV Recombinant S Protein, With and Without Adjuvant, Vaccine Study [Phase 1]